| Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s reportable segments are: the Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products. |
When researching a stock like Merck, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from MRK Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for MRK stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the MRK 200 day moving average ("MRK 200 DMA"), while one of the most popular "shorter look-backs" is the MRK 50 day moving average ("MRK 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Merck. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the MRK 200 DMA and the MRK 50 DMA, we get a moving average convergence divergence indicator ("MRK MACD"). The MRK MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart).